| Filed On | Filing |
|---|---|
| 14 Nov 2025 | SCHEDULE 13G/A |
| 21 Aug 2025 | 15-12G |
| 12 Aug 2025 |
Form 4: Orbimed Advisors Llc, Director and 1 other
Disposed of 3,099,265 shares (Tender Offer) |
| 12 Aug 2025 | SCHEDULE 13D/A |
| 12 Aug 2025 |
Form 4: Versant Ventures V, Llc, 10% owner and 9 others
Disposed of 3,381,692 shares (Tender Offer) |
| 11 Aug 2025 | S-8 POS |
| 11 Aug 2025 | S-8 POS |
| 11 Aug 2025 | SC 14D9/A |
| 11 Aug 2025 | 25-NSE |
| 11 Aug 2025 | SC TO-T/A |
| 11 Aug 2025 | 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more |
| 08 Aug 2025 |
Form 4: Jerel Davis, Director
Disposed of 3,381,692 shares (Tender Offer) |
| 08 Aug 2025 |
Form 4: Gupta Rishi, Director
Disposed of 3,099,265 shares (Tender Offer) |
| 08 Aug 2025 | 10-Q |
| 24 Jul 2025 | SC TO-T/A |
| 18 Jul 2025 | UPLOAD |
| 17 Jul 2025 | SC 14D9/A |
| 17 Jul 2025 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This letter sets forth the terms of the separation agreement (the “Agreement”) that Turnstone Biologics Corp. (“Turnstone” or the “Company”) is offering to you to aid in your employment transition. |
| 11 Jul 2025 | SC 14D9 |
| 11 Jul 2025 | SC TO-T |
Loading...
